APA (7th ed.) Citation

F, O., D, B., N, P., T, Z., A, M., T, F., . . . M, B. (2019). International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study. Frontiers in pharmacology, 10, 1177. https://doi.org/10.3389/fphar.2019.01177

Chicago Style (17th ed.) Citation

F, Ofek, Barchel D, Perets N, Ziv-Baran T, Mahajna A, Filipovich-Rimon T, Garach-Jehoshua O, Berlin M, and Berkovitch M. "International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study." Frontiers in Pharmacology 10 (2019): 1177. https://doi.org/10.3389/fphar.2019.01177.

MLA (9th ed.) Citation

F, Ofek, et al. "International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study." Frontiers in Pharmacology, vol. 10, 2019, p. 1177, https://doi.org/10.3389/fphar.2019.01177.